EVELYN DENNISON: Open Payments
NPI 1982921540 · KIRKLAND, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$317 in 8 payments from 7 companies in 2025. Trend: 2023 $15 · 2024 $349 · 2025 $317
Food & beverage: $317
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $100 |
| E.R. Squibb & Sons, L.L.C. | 1 | $90 |
| ABBVIE INC. | 2 | $38 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Janssen Scientific Affairs, LLC | 1 | $22 |
| Tris Pharma Inc | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
Products named: CAPLYTA, COBENFY, VRAYLAR, Auvelity, SPRAVATO, Dyanavel XR, REXULTI.
Industry payments across WA — which companies pay providers there.
